Alison Freeman-Gleason

Of Counsel
Full contact info

I enjoy being part of our clients’ teams, working closely with them to understand their goals, and bringing my 25+ years of experience to structure, draft and negotiate agreements that help fulfill those goals.

Experience

Otsuka Pharmaceutical Announces Global Strategic Collaboration With Harbour BioMed

June 23, 2025

Cooley advised Otsuka Pharmaceutical, a total healthcare company focused on each individual’s potential to enhance their well-being, on its global strategic collaboration with Harbour BioMed to advance BCMAxCD3 bispecific T-cell engagers for treating autoimmune diseases.

Read more

Related contacts

Jennifer Raab
Partner, Palo Alto
Alison Freeman-Gleason
Of Counsel, Seattle
Rachel Thorn
Of counsel, New York
Zack Gong
Associate, Shanghai
Freddy Yip
Associate, Hong Kong
Jonathan Kaufman
Associate, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Robert Eisenbach
Of Counsel, San Francisco
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

LIXTE Announces Three-Way Clinical Trial Agreement With GSK and MD Anderson

September 20, 2023

Cooley advised LIXTE Biotechnology, a clinical-stage pharmaceutical company focused on developing and commercializing new cancer therapies, on its clinical trial agreement with The University of Texas MD Anderson Cancer Center and GSK.

Read more

Related contacts

Alison Freeman-Gleason
Of Counsel, Seattle
Dr. Matthew Langer
Senior Counsel , New York

Related Practices & Industries

Bridge to Life Sells Certain Assets to TransMedics

August 3, 2023

Cooley advised Bridge to Life, an organ preservation and perfusion technologies supplier, on its sale of certain assets – including its EVOSS heart and lung and LifeCradle heart perfusion assets – to TransMedics.

Read more

Related contacts

Rowook Park
Partner, San Diego
Jenny Ge
Associate, Santa Monica
Alison Freeman-Gleason
Of Counsel, Seattle
Lauren Creel
Partner, Palo Alto
Rishab Kumar
Partner, Palo Alto
Jonathan Rivinus
Partner, Colorado
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Ross Eberly
Partner, Santa Monica
Howard Morse
Senior Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Justin Kisner
Special Counsel, San Diego
Stella Sarma
Partner, Brussels
Jameson Davis
Associate, Boston
Cara Buchicchio
Associate, New York
Xenia Chiu
Associate, Singapore
Rubin Waranch
Associate, Colorado
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

Otsuka Enters Worldwide Collaboration Agreement With Sunovion and Sumitomo Dainippon Pharma

October 13, 2021

Cooley advised Otsuka Pharmaceutical, a global healthcare company, on its worldwide collaboration and license agreement with biopharmaceutical company Sunovion Pharmaceuticals and parent company Sumitomo Dainippon Pharma for the joint development and commercialization of four novel candidate compounds. Lawyers Alison Freeman-Gleason and Brian Stalter led the Cooley team advising Otsuka.

Read more

Related contacts

Alison Freeman-Gleason
Of Counsel, Seattle
J. Brian Stalter
Special Counsel, New York
David Burns
Special Counsel, Washington, DC
Georgina Dietrich
Associate, Brussels
Marc Suskin
Partner, New York

Related Practices & Industries

Molecular Templates Enters Collaboration With Bristol Myers Squibb for Cancer Treatment

February 26, 2021

Cooley advised clinical-stage biopharmaceutical company, Molecular Templates (MTEM), on its strategic research collaboration with Bristol Myers Squibb to discover and develop therapies designed for specific oncology targets. The collaboration will seek to discover new molecules utilizing MTEM’s next-generation engineered toxin body (ETB) platform. Lawyers Alison Freeman-Gleason and Kristy Brady led the Cooley team advising MTEM.

Read more

Related contacts

Alison Freeman-Gleason
Of Counsel, Seattle

Related Practices & Industries

View more

Admissions and credentials

Connecticut

Washington

Memberships and affiliations

Washington State Bar Association

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.